Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Financial Flexibility Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥116.82 Million (operating CF CN¥109.83 Million minus capex CN¥6.99 Million) represents 0% of total liabilities (CN¥676.78 Million). Check how strategically is Shanghai Shenqi Pharmaceutical Investmen's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 28 annual periods. See Shanghai Shenqi Pharmaceutical Investmen current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Year-by-year free cash flow to debt coverage for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. For the full company profile including market capitalisation, see market value of Shanghai Shenqi Pharmaceutical Investmen.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | CN¥157.69 Million | CN¥124.47 Million | CN¥747.59 Million | ▼ -40.5% |
| 2024 | 0.35x | CN¥244.18 Million | CN¥207.79 Million | CN¥689.01 Million | ▲ +31.2% |
| 2023 | 0.27x | CN¥240.10 Million | CN¥215.59 Million | CN¥888.77 Million | ▼ -21.3% |
| 2022 | 0.34x | CN¥345.87 Million | CN¥319.23 Million | CN¥1.01 Billion | ▼ -3.9% |
| 2021 | 0.36x | CN¥270.23 Million | CN¥184.26 Million | CN¥756.45 Million | ▲ +40.8% |
| 2020 | 0.25x | CN¥195.40 Million | CN¥99.10 Million | CN¥770.28 Million | ▲ +10.6% |
| 2019 | 0.23x | CN¥205.24 Million | CN¥128.28 Million | CN¥894.60 Million | ▼ -53.2% |
| 2018 | 0.49x | CN¥258.77 Million | CN¥148.53 Million | CN¥527.74 Million | ▲ +57.7% |
| 2017 | 0.31x | CN¥175.83 Million | CN¥66.99 Million | CN¥565.34 Million | ▲ +306.3% |
| 2016 | 0.08x | CN¥43.44 Million | CN¥570.41K | CN¥567.56 Million | ▼ -69.4% |
| 2015 | 0.25x | CN¥96.30 Million | CN¥30.12 Million | CN¥384.98 Million | ▲ +23.5% |
| 2014 | 0.20x | CN¥51.75 Million | CN¥-8.62 Million | CN¥255.60 Million | ▼ -71.5% |
| 2013 | 0.71x | CN¥130.33 Million | CN¥74.75 Million | CN¥183.42 Million | ▲ +270.2% |
| 2012 | -0.42x | CN¥-10.15 Million | CN¥-11.18 Million | CN¥24.31 Million | ▼ -1014.9% |
| 2011 | -0.04x | CN¥-1.18 Million | CN¥-3.33 Million | CN¥31.57 Million | ▼ -103.2% |
| 2010 | 1.18x | CN¥33.61 Million | CN¥33.04 Million | CN¥28.48 Million | ▲ +731.8% |
| 2009 | 0.14x | CN¥8.60 Million | CN¥7.69 Million | CN¥60.61 Million | ▼ -70.6% |
| 2008 | 0.48x | CN¥25.62 Million | CN¥25.26 Million | CN¥53.04 Million | ▲ +157.6% |
| 2007 | 0.19x | CN¥16.91 Million | CN¥16.01 Million | CN¥90.23 Million | ▲ +503.9% |
| 2006 | -0.05x | CN¥-4.88 Million | CN¥-6.05 Million | CN¥105.19 Million | ▼ -114.1% |
| 2005 | 0.33x | CN¥36.22 Million | CN¥32.72 Million | CN¥109.67 Million | ▲ +443.1% |
| 2004 | 0.06x | CN¥11.25 Million | CN¥4.96 Million | CN¥184.98 Million | ▲ +65.4% |
| 2003 | 0.04x | CN¥5.15 Million | CN¥4.52 Million | CN¥139.96 Million | ▼ -72.6% |
| 2002 | 0.13x | CN¥19.26 Million | CN¥16.02 Million | CN¥143.38 Million | ▲ +217.9% |
| 2001 | -0.11x | CN¥-17.91 Million | CN¥-20.51 Million | CN¥157.14 Million | ▼ -149.9% |
| 2000 | 0.23x | CN¥38.61 Million | CN¥26.85 Million | CN¥168.97 Million | ▲ +4.0% |
| 1999 | 0.22x | CN¥32.83 Million | CN¥-3.28 Million | CN¥149.46 Million | ▲ +14.1% |
| 1998 | 0.19x | CN¥74.01 Million | CN¥72.67 Million | CN¥384.28 Million | — |